Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA array technology and diagnostic microbiology.

R M Anthony1, T J Brown, G L French

  • 1NH Swellengrebel Laboratorium, voor Tropical Hygiene, Mibergdreef 39, 1105 AZ, Amsterdam, The Netherlands.

Expert Review of Molecular Diagnostics
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring recent in-country TB transmission using a classification model with whole genome sequencing data.

IJTLD open·2026
Same author

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area.

Microbiology spectrum·2022
Same author

The impact of diabetes mellitus on pulmonary TB.

Public health action·2022
Same author

'Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.' Do we have enough pieces to solve the pyrazinamide puzzle?

The Journal of antimicrobial chemotherapy·2018
Same author

Exploring the evidence base for Tier 3 weight management interventions for adults: a systematic review.

Clinical obesity·2017
Same author

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.

Antimicrobial agents and chemotherapy·2017
Same journal

Bacterial respiratory infections: advances in diagnostic strategies.

Expert review of molecular diagnostics·2026
Same journal

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
See all related articles

Array-based assays offer rapid pathogen detection and antimicrobial resistance prediction, revolutionizing infection management. These diagnostic tools are becoming increasingly vital for clinical microbiology applications.

Area of Science:

  • Clinical microbiology
  • Molecular diagnostics
  • Biotechnology

Background:

  • Current microbiology diagnostics are time-consuming.
  • Antimicrobial resistance (AMR) requires rapid detection for effective treatment.
  • Array-based technologies are emerging from research into routine applications.

Purpose of the Study:

  • To highlight the potential of array-based assays for clinical diagnostics.
  • To discuss the integration of microfluidics with array technologies.
  • To emphasize the future role of arrays in microbiology.

Main Methods:

  • Utilizing array-based assays for simultaneous detection of pathogens.
  • Employing DNA microarrays for monitoring gene expression.
  • Integrating microfluidics for purification, amplification, and detection.

Related Experiment Videos

Main Results:

  • Array-based assays enable rapid, simultaneous determination of multiple characteristics.
  • Microfluidic systems offer a pathway for integrated sample-to-answer diagnostics.
  • Cost reduction and development of targeted arrays are driving adoption.

Conclusions:

  • Array-based assays are poised to become crucial tools in clinical diagnostics.
  • The combination of microfluidics and microarrays promises streamlined infectious disease management.
  • Near-instantaneous pathogen identification and AMR profiling will transform patient care.